GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the SARS-cov-2 rbd in complex with the human antibody CV2.6264

Analyse Crystal structure of the SARS-cov-2 rbd in complex with the human antibody… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7QF1
Type
protein
Length
1,248 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Spike protein S1; CV2.6264 light chain; CV2.6264 heavy chain
UniProt
P0DTC2
Ligands
NAG, BMA
Pockets
10 · best druggability 0.83

Structure

x-ray diffraction · 5 distinct chains · 10% helix, 43% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASpike protein S1protein19415% helix, 29% strandP0DTC2
FSpike protein S1protein19016% helix, 29% strandP0DTC2
B, DCV2.6264 light chainprotein2137% helix, 50% strand—
CCV2.6264 heavy chainprotein2195% helix, 51% strand—
ECV2.6264 heavy chainprotein2197% helix, 52% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains A, D, F, B
  • BMA · beta-D-mannopyranose · sugar

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19790.830.8495empty
24350.580.7447empty
34140.580.7548empty
42590.510.7530empty
51920.460.7536empty

Interfaces

9 interfaces between chains.

  • D–E · 1723 Ų buried · 12 hydrogen bonds · protein-protein
  • B–C · 1695 Ų buried · 12 hydrogen bonds · protein-protein
  • A–F · 635 Ų buried · 9 hydrogen bonds · protein-protein
  • A–C · 582 Ų buried · 10 hydrogen bonds · protein-protein
  • F–E · 546 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 16 disulfide, 2 glycan (disulfide, N-glycosylation).

Compared structures

  • 7QF1 · Crystal structure of the SARS-CoV-2 RBD in complex with the human antibody CV2.6264 · the same entry in another collection · chain E against E, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.